NYSE:WST | Free Cash Flow | WEST PHARMACEUTICAL SERVICES INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2008-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$89.9M$42.7M$47.2M34.01%
2025-12-31$251.1M$76.1M$175M132.48%
2025-03-31$129.4M$71.3M$58.1M64.70%
2024-12-31$190.1M$104.9M$85.2M65.49%
2024-03-31$118.2M$90.6M$27.6M23.94%
2023-12-31$239.1M$108.7M$130.4M95.18%
2023-03-31$138.1M$82.1M$56M40.00%
2022-12-31$230.8M$94.9M$135.9M131.94%
2022-03-31$151.2M$65.8M$85.4M49.14%
2021-12-31$160.8M$76.5M$84.3M57.08%
2021-03-31$88.7M$54.7M$34M22.49%
2020-12-31$148.7M$57.7M$91M92.48%
2020-03-31$57.1M$32.1M$25M33.65%
2019-12-31$106.4M$37.6M$68.8M107.67%
2019-03-31$47.6M$28.8M$18.8M33.94%
2018-12-31$73.2M$30M$43.2M83.08%
2018-03-31$45M$28M$17M38.99%
2017-12-31$81.5M$29.5M$52M
2017-03-31$20.7M$37.5M-$16.8M-27.59%
2016-12-31$71.8M$47.5M$24.3M62.15%
2016-03-31$3M$39M-$36M-162.90%
2015-12-31$68M$44.8M$23.2M69.46%
2015-03-31-$1.9M$30.4M-$32.3M-98.18%
2014-12-31$46M$27.1M$18.9M60.19%
2014-03-31$8.8M$31.7M-$22.9M-84.50%
2013-12-31$68.8M$38.8M$30M127.12%
2013-03-31$18.9M$61.7M-$42.8M-135.02%
2012-12-31$69.8M$32.9M$36.9M174.88%
2012-03-31$13.8M$32.4M-$18.6M-63.70%
2011-12-31$41.8M$33.4M$8.4M44.68%
2011-03-31$9.5M$19.4M-$9.9M-50.51%
2010-12-31$47.2M$21.3M$25.9M431.67%
2010-03-31$11.5M$17.7M-$6.2M-31.31%
2009-12-31$52.6M$28.5M$24.1M118.72%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$754.8M$285.9M$468.9M94.98%
2024-12-31$653.4M$377M$276.4M56.10%
2023-12-31$776.5M$362M$414.5M69.85%
2022-12-31$724M$284.6M$439.4M75.00%
2021-12-31$584M$253.4M$330.6M49.95%
2020-12-31$472.5M$174.4M$298.1M86.11%
2019-12-31$367.2M$126.4M$240.8M99.63%
2018-12-31$288.6M$104.7M$183.9M88.88%
2017-12-31$263.3M$130.8M$132.5M87.92%
2016-12-31$219.4M$170.2M$49.2M34.26%
2015-12-31$212.4M$131.6M$80.8M84.52%
2014-12-31$182.9M$111.9M$71M55.86%
2013-12-31$220.5M$151.9M$68.6M61.09%
2012-12-31$187.4M$131.3M$56.1M69.52%
2011-12-31$130.7M$95.4M$35.3M46.75%
2010-12-31$138.3M$71.1M$67.2M102.91%
2009-12-31$137.7M$104.9M$32.8M45.18%
2008-12-31$135M$138.6M-$3.6M-4.19%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.